Références
American Psychiatric Association, Diagnostic and statistical manual of mental disorders: Fifth Edition (2013) New School Library
Keski-Rahkonen A, Mustelin L (2016) Epidemiology of eating disorders in Europe: prevalence, incidence, comorbidity, course, consequences, and risk factors. Curr Opin Psychiatry. 29:340–5
Smink FR, van Hoeken D, Hoek HW (2012) Epidemiology of eating disorders: incidence, prevalence and mortality rates. Curr Psychiatry Rep 14:406–14
Hoek HW. Review of the worldwide epidemiology of eating disorders (2016) Curr Opin Psychiatry. 29:336–9
Vu-Augier de Montgrémier M, Blanchet-Collet C, Guzman G, Moro MR. Toward a transcultural approach to eating disorders (2016)Soins Psychiatr. 37:22–24
Gorwood P, Blanchet-Collet C, Chartrel N, et al (2016) New Insights in Anorexia Nervosa. Frontiers in Neurosciences. 10:256
Gorwood P, Blanchet-Collet C, Charterl N et al (2016) New insights in anorexia nervosa. Frontiers Neurosc 10:256.
Tennoune N, Chan P, Breton J et al (2014) Bacterial ClpB heat-shock protein, an antigen-mimetic of the anorexigenic peptide α-MSH, at the origin of eating disorders. Transl Psychiatry 4:e458.
Breton J, Tennoune N, Lucas N et al (2016) Gut commensal E. Coli proteins activate host satiety pathways following nutrient-induced bacterial growth. Cell Metab 23:1–11.
Fetissov SO (2016) Role of the gut microbiota in host appetite control: bacterial growth to animal feeding behaviour. Nat Rev Endoc 13:11–25.
Breton R, Akkermann K, Järv A (2016) Elevated plasma concentrations of bacterial ClpB protein in patients with eating disorders. Int J Eat Disord 49:805–8.
Takagi K, Legrand R, Asakawa A et al (2013) Antighrelin immunoglobulins modulate ghrelin stability and its orexigenic effect in obese mice and humans. Nat Comm 4:2685.
Burgess EE, Sylvester MD, Morse KE et al (2016) Effects of transcranial direct current stimulation (tDCS) on binge eating disorder. Int. J. Eat. Disord. 49:930–36.
Val-Laillet D, Aarts E, Weber B et al (2015) Neuroimaging and neuromodulation approaches to study eating behavior and prevent and treat eating disorders and obesity. NeuroImage Clin 8:1–31.
McClelland J, Kekic M, Bozhilova N et al (2016) A Randomised Controlled Trial of Neuronavigated Repetitive Transcranial Magnetic Stimulation (rTMS) in Anorexia Nervosa. PloS One 11:e0148606.
Hatch A, Madden S, Kohn MR et al (2011) Eeg in adolescent anorexia nervosa: Impact of refeeding and weight gain. Int J Eat Disord 44:65–75.
Imperatori C, Valenti EM, Della Marca G et al (2017) Co** food craving with neurofeedback. Evaluation of the usefulness of alpha/theta training in a non-clinical sample. Int J Psychophysiol 112:89–97.
Bloomgarden A, Calogero RM (2008) A randomized experimental test of the efficacy of EMDR treatment on negative body image in eating disorder inpatients. Eat Disord 16, 418–27.
Littel M., van den Hout MA, Engelhard IM (2016) Desensitizing Addiction: Using Eye Movements to Reduce the Intensity of Substance-Related Mental Imagery and Craving. Front. Psychiatry 7:14.
Lattimore P, Mead BR, Irwin L et al (2017) ‘I can’t accept that feeling’: Relationships between interoceptive awareness, mindfulness and eating disorder symptoms in females with, and at-risk of an eating disorder. Psychiatry Res. 247:163–71.
Godfrey KM, Gallo LC, Afari N (2015) Mindfulnessbased interventions for binge eating: a systematic review and meta-analysis. J Behav Med 38:348–62.
Clarke J, Ramoz N, Fladung AK, Gorwood P (2016) Higher reward value of starvation imagery in Anorexia Nervosa and association with the Val66Met BDNF polymorphism. Translational Psychiatry (in Press)
Myung SK, Ju W, Cho B, et al (2013) Efficacy of vitamin and antioxidant supplements in prevention of cardiovascular disease: systematic review and meta-analysis of randomized controlled trials. BMJ. 18:346.
Curtis AJ, Bullen M, Piccenna L, et al (2014) Vitamin E supplementation and mortality in healthy people: a metaanalysis of randomised controlled trials. Cardiovasc Drugs Ther. 28:563–73.
Bjelakovic G, Nikolova D, Gluud LL, et al (2007) Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA. 297:842–57.
Loffredo L, Perri L, Di Castelnuovo A, et al (2015) Supplementation with vitamin E alone is associated with reduced myocardial infarction: a meta-analysis. Nutr Metab Cardiovasc Dis. 25:354–63.
Hansel B, Roussel R, Diguet V, et al (2015) Relationships between consumption of alcoholic beverages and healthy foods: the French supermarket cohort of 196,000 subjects. Eur J Prev Cardiol. 22:215–22.
Hansel B, Thomas F, Pannier B, et al (2010) Relationship between alcohol intake, health and social status and cardiovascular risk factors in the Urban Paris-Ile-de-France Cohort: is the cardioprotective action of alcohol a myth? Eur J Clin Nutr. 64:561–8.
Muraro A, Werfel T, Hoffmann-Sommergruber K, et al (2014). EAACI food allergy and anaphylaxis guidelines: diagnosis and management of food allergy. Allergy 69:1008–25.
Beaudouin B, Renaudin JM, Sergeant P, et al (2009) Les principaux diagnostics différentiels en allergie alimentaire. Revue Française d’Allergologie. 49: 291–5.
Grillot J, Galmiche M, Antunès O, et al (2016) Nutrition Clinique et Métabolisme. 30:98–104.
http://www.afdiag.fr/intolerance-au-gluten/la-maladiecoeliaque
Chabane H (2015) Un test inutile: le dosage des IgG spécifiques anti-aliments. Revue Française d’Allergologie. 55:134–6
Moneret-Vautrin DA, Kanny G, Morisset M (2006) Les allergies alimentaires de l’enfant et de l’adulte. Ed. Elsevier Masson
Biesiekierski JR, Newnham ED, Irving PM, et al (2011). Gluten causes gastrointestinal symptoms in subjects without celiac disease: a double-blind randomized placebo-controlled trial. Am J Gastroenterol. 106:508–14.
Catassi C, Elli L, Bonaz B, et al (2015). Diagnosis of Non-Celiac Gluten Sensitivity (NCGS): The Salerno Experts’ Criteria. Nutrients 7:4966–77.
Elli L, Branchi F, Tomba C, et al (2015) Diagnosis of gluten related disorders: Celiac disease, wheat allergy and non-celiac gluten sensitivity. World J Gastroenterol 21:7110–9.
Fasano A, Sapone A, Zevallos V, et al (2015) Noncoeliac gluten and wheat sensitivity. Gastroenterology 148:1195–204.
Halmos EP, Power VA, Shepherd SJ, et al (2014) A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Gastroenterology 146:67–75.
Malamut G, Cellier C (2012) Place et bilan de la maladie coeliaque. Hepato Gastro. 19:597–606.
Shepherd SJ, Halmos E, Glance S (2014) The role of FODMAPs in irritable bowel syndrome. Curr Opin Clin Nutr Metab Care. 17:605–9.
Misselwitz B, Pohl D, Frühauf H, et al (2013) Lactose malabsorption and intolerance: pathogenesis, diagnosis and treatment. United Eur Gastroenterol J. 1:151–9.
Itan Y, Powell A, Beaumont MA et al (2009) The origins of lactase persistence in Europe. PLoS Comput Biol. 5: e1000491.
Deng Y, Misselwitz B, Dai N, et al (2015) Lactose Intolerance in Adults: Biological Mechanism and Dietary Management. Nutrients. 7:8020–35.
Lule VK, Garg S, Tomar SK, et al (2016) Food Intolerance: Lactose Intolérance. Module in Food Science, from Encyclopedia of Food and Health. p. 43–48.
Marteau A, Marteau Ph (2005) Entre intolérance au lactose et maldigestion. Cah. Nutr. Diet. 40: 20–3.
Morin MC (2015) Prise en soin diététique de l’intolérant au lactose: quand et comment? Information Diététique. 3: 20–30.
Lukito W, Malik SG, Surono IS, et al (2015). From “lactose intolerance” to “lactose nutrition”. Asia Pac J Clin Nutr. 24:1–8.
Le jeûne, nouvelle arme de lutte contre le cancer ? (2002) Le Monde.
Lee C, Raffaghello L, Brandhorst S, et al (2012) Fasting cycles retard growth of tumors and sensitize a range of cancer cell types to chemotherapy. Science translational medicine. 4:124–27.
Lee C, Longo VD (2011) Fasting vs d ietary restriction in cellular protection and cancer treatment: from model organisms to patients. Oncogene. 30:3305–16.
Raffaghello L, Lee C, Safdie FM, et al (2008) Starvation dependent differential stress resistance protects normal but not cancer cells against high-dose chemotherapy. Proceedings of the National Academy of Sciences of the United States of America. 105:8215–20.
Pressoir M, Desne S, Berchery D, et al (2010) Prevalence, risk factors and clinical implications of malnutrition in French Comprehensive Cancer Centres. British journal of cancer. 102:966–71.
Clément K, Vaisse C, Lahlou N, et al (1998) A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature. 392:398–401.
Vaisse C, Clement K, Guy-Grand B, et al (1998) A frameshift mutation in human MC4R is associated with a dominant form of obesity. Nat Genet. 20:113–4.
Farooqi IS1, Yeo GS, Keogh JM, et al (2000) Dominant and recessive inheritance of morbid obesity associated with melanocortin 4 receptor deficiency. J Clin Invest. 106:271–9.
Nizard J, Dommergues M, Clément K (2012) Pregnancy in a woman with a leptin-receptor mutation. N Engl J Med. 366:1064–5.
Elefteriou F, Ahn JD, Takeda S, et al (2005) Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature. 434:514–20.
Clément K, Dubern B, Mencarelli M, et al (2008) Unexpected endocrine features and normal pigmentation in a young adult patient carrying a novel homozygous mutation in the POMC gene. J Clin Endocrinol Metab. 93:4955–62.
Mencarelli M, Dubern B, Alili R, et al (2011) Rare melanocortin-3 receptor mutations with in vitro functional consequences are associated with human obesity. Hum Mol Genet. 20:392–9.
Huvenne H, Le Beyec J, Pépin D, et al (2015) Seven novel deleterious LEPR mutations found in early-onset obesity: a ΔExon6-8 shared by subjects from Reunion Island, France, suggests a founder effect. J Clin Endocrinol Metab. 100:e757–66.
Roubert P, Dubern B, Plas P, et al (2010) Novel pharmacological MC4R agonists can efficiently activate mutated MC4R from obese patient with impaired endogenous agonist response. J Endocrinol. 207:177–83.
Kühnen P, Clément K, Wiegand S et al (2016) Proopiomelanocortin Deficiency Treated with a Melanocortin-4 Receptor Agonist. N Engl J Med. 375:240–6.
Henegar C, Tordjman J, Achard V, et al (2008). Adipose tissue transcriptomic signature highlights the pathological relevance of extracellular matrix in human obesity. Genome Biol. 9:14.
Dalmas E, Toubal A, Alzaid F, et al (2015) Irf5 deficiency in macrophages promotes beneficial adipose tissue expansion and insulin sensitivity during obesity. Nat Med. 21:610–8.
Pellegrinelli V, Heuvingh J, du Roure O et al (2014) Human adipocyte function is impacted by mechanical cues. J Pathol. 233:183–95.
Venteclef N, Guglielmi V, Balse E, et al (2015) Human epicardial adipose tissue induces fibrosis of the atrial myocardium through the secretion of adipo-fibrokines. Eur Heart J. 36:795–805.
Liu Y, Aron-Wisnewsky J, Marcelin G, et al (2016) Accumulation and changes in composition of collagens in subcutaneous adipose tissue after bariatric surgery. J Clin Endocrinol Metab. 101:293–304.
Monteiro-Sepulveda M, Touch S, Mendes-Sà C, et al (2015) Jejunal T Cell Inflammation in Human Obesity Correlates with Decreased Enterocyte Insulin Signaling. Cell Metab. 22:113–24.
Divoux A, Tordjman J, Lacasa D, et al (2010) Fibrosis in human adipose tissue: composition, distribution, and link with lipid metabolism and fat mass loss. Diabetes. 59:2817–25.
Cotillard A, Kennedy SP, Kong LC, et al (2013) Dietary intervention impact on gut microbial gene richness. Nature. 500:585–8.
Dao MC, Everard A, Aron-Wisnewsky J, et al (2015) Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology. Gut 65:426–36.
Shoaie S, Ghaffari P, Kovatcheva-Datchary P et al (2015). Quantifying Diet-Induced Metabolic Changes of the Human Gut Microbiome. Cell Metab. 22:320–31.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pigeyre, M. Journée annuelle Benjamin Delessert 1er février 2017. Obes 12, 47–62 (2017). https://doi.org/10.1007/s11690-017-0553-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11690-017-0553-1